About Pila pharma ab

About company

Pila Pharma AB is developing a new class of orally active drugs for the treatment of newly diagnosed type 2 diabetes. PILA PHARMA is a privately held clinical stage pharmaceutical company based in Malmö, Sweden. PILA PHARMA is developing a novel type of oral anti-diabetic agent: a TRPV1 antagonist for the treatment of diabetes. The company owns issued use-patents giving the right to treat diabetes and obesity with TRPV1 antagonists. Our safe clinical development candidate, XEN-D0501, entered the first clinical trials in type-2 diabetic patients in 2017.